Expand DBVT Menu
DBVT MENU

DBVT Latest Press Releases

-- April 2, 2026 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 Globe Newswire 4:30 PM

-- March 26, 2026 --

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document Globe Newswire 5:19 PM
DBV Technologies Reports Full Year 2025 Financial Results and Business Update Globe Newswire 5:06 PM

-- March 24, 2026 --

DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Globe Newswire 4:30 PM

-- March 4, 2026 --

DBV Technologies to Participate in Upcoming March Investor Conferences Globe Newswire 4:30 PM

-- March 3, 2026 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 Globe Newswire 4:30 PM

-- February 28, 2026 --

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting Globe Newswire 2:25 PM

-- February 10, 2026 --

DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting Globe Newswire 4:30 PM

-- February 9, 2026 --

DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit Globe Newswire 4:30 PM

-- February 5, 2026 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026 Globe Newswire 4:30 PM

-- January 16, 2026 --

DBV Technologies Announces EUR 166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing Globe Newswire 6:11 PM

-- January 12, 2026 --

Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 Globe Newswire 4:00 PM

-- January 7, 2026 --

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF Globe Newswire 4:00 PM

-- January 5, 2026 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 Globe Newswire 4:00 PM

-- December 16, 2025 --

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN Peanut Patch in Peanut Allergic Children Aged 4-7 Years Globe Newswire 4:05 PM

-- December 2, 2025 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025 Globe Newswire 4:00 PM

-- November 11, 2025 --

DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN Peanut Patch in Peanut Allergic Children Aged 4-7 Years Globe Newswire 11:50 PM
Market Data Delayed 15 Minutes